Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06223620 · ClinicalTrials.gov registry record
A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction
A clinical trial of SBO - Small Bowel Obstruction, sponsored by Methodist Health System.
- Completed
- Registry status
- 504
- Enrollment target
- 1
- Study location
NCT06223620: Completed study of SBO - Small Bowel Obstruction, sponsored by Methodist Health System.
NCT06223620 is a study of SBO - Small Bowel Obstruction that has completed, run by Methodist Health System. The registered enrollment target is 504 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06223620, a study of SBO - Small Bowel Obstruction, has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 504 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.
Primary Outcome
Morbidity and length of stay
Conditions Studied
Interventions
- OTHER review performance of water soluble contrast
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 504 participants |
| Start Date | 2018-07-30 |
| Est. Completion | 2019-12-31 |
What the finished NCT06223620 record still lists
NCT06223620 is an observational study that tracks outcomes without assigning an intervention. The registered 504 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with SBO - Small Bowel Obstruction appearing as the primary indexed condition, and to 1 intervention - of which review performance of water soluble contrast is the first listed.
NCT06223620 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06223620 about?
NCT06223620 is a clinical study titled "A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction". The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.
What is the current status of trial NCT06223620?
This trial is currently completed. The enrollment target is 504 participants. The study started on 2018-07-30. Estimated completion is 2019-12-31.
What conditions does trial NCT06223620 study?
This clinical trial studies the following conditions: SBO - Small Bowel Obstruction.
What interventions are being tested in trial NCT06223620?
The interventions under investigation include: review performance of water soluble contrast (OTHER).
Who is sponsoring clinical trial NCT06223620?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06223620 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05846282 · 504 participants · NA
Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience
- NCT06072131 · 504 participants · Phase 3
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
- NCT06736522 · 504 participants · NA
Future Leaders Program: Testing a Youth Leadership, Engagement, and Mindfulness Program
- NCT06822257 · 504 participants · NA
Drinking in Young Adult Duos (DYAD) Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI